von Willebrand Disease Panel
The von Willebrand Disease Panel assesses von Willebrand factor antigen (vWF:Ag), ristocetin cofactor activity, factor VIII coagulant activity, and vWF multimer distribution to diagnose or subtype von Willebrand disease. It helps distinguish quantitative versus qualitative VWF defects, guiding bleeding risk evaluation, therapeutic planning, and personalized management of VWD subtypes.
- $793.96
- $382
- Save: 51.89%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: von Willebrand (VWF) Comprehensive Panel
Coag Factor Viii Activity
Partial Thromboplastin
Ristocetin Cofactor
Von Willebrand Factor
Vwf Ag, Multimeric
The von Willebrand Disease Panel test contains 1 test with 5 biomarkers .
Von Willebrand disease is a bleeding disorder that slows the blood clotting process, causing prolonged bleeding after an injury. People with this condition often experience easy bruising, long-lasting nosebleeds, and excessive bleeding or oozing following an injury, surgery, or dental work. Von Willebrand disease is estimated to affect 1 in 100 to 10,000 individuals. Because people with mild signs and symptoms may not come to medical attention, it is thought that this condition is underdiagnosed. Most researchers agree that von Willebrand disease is the most common genetic bleeding disorder.